Blood groups and malaria: fresh insights into pathogenesis and identification of targets for intervention

Por Rowe, J. Alexandra, Opi, D. Herbert, Williams, Thomas N.
Publicado em 2009

Red blood cell complement receptor one level varies with Knops blood group, α(+)thalassaemia and age among Kenyan children

Por Opi, D H, Uyoga, S, Orori, E N, Williams, T N, Rowe, J A
Publicado no Genes Immun (2016)

Enzymatically Active APOBEC3G Is Required for Efficient Inhibition of Human Immunodeficiency Virus Type 1

Por Miyagi, Eri, Opi, Sandrine, Takeuchi, Hiroaki, Khan, Mohammad, Goila-Gaur, Ritu, Kao, Sandra, Strebel, Klaus
Publicado em 2007

Production of infectious human immunodeficiency virus type 1 does not require depletion of APOBEC3G from virus-producing cells

Por Goila-Gaur Ritu, Opi Sandrine, Takeuchi Hiroaki, Khan Mohammad A, Miyagi Eri, Kao Sandra, Strebel Klaus
Publicado em 2004-09-01

Production of infectious human immunodeficiency virus type 1 does not require depletion of APOBEC3G from virus-producing cells

Por Kao, Sandra, Miyagi, Eri, Khan, Mohammad A, Takeuchi, Hiroaki, Opi, Sandrine, Goila-Gaur, Ritu, Strebel, Klaus
Publicado em 2004

Analysis of the contribution of cellular and viral RNA to the packaging of APOBEC3G into HIV-1 virions

Por Khan, Mohammad A, Goila-Gaur, Ritu, Opi, Sandrine, Miyagi, Eri, Takeuchi, Hiroaki, Kao, Sandra, Strebel, Klaus
Publicado em 2007

Human Immunodeficiency Virus Type 1 Vif Inhibits Packaging and Antiviral Activity of a Degradation-Resistant APOBEC3G Variant

Por Opi, Sandrine, Kao, Sandra, Goila-Gaur, Ritu, Khan, Mohammad A., Miyagi, Eri, Takeuchi, Hiroaki, Strebel, Klaus
Publicado em 2007

Production of infectious virus and degradation of APOBEC3G are separable functional properties of human immunodeficiency virus type 1 Vif

Por Kao, Sandra, Goila-Gaur, Ritu, Miyagi, Eri, Khan, Mohammad A., Opi, Sandrine, Takeuchi, Hiroaki, Strebel, Klaus
Publicado em 2007

Protein–protein interaction inhibition (2P2I) combining high throughput and virtual screening: Application to the HIV-1 Nef protein

Por Betzi, Stéphane, Restouin, Audrey, Opi, Sandrine, Arold, Stefan T., Parrot, Isabelle, Guerlesquin, Françoise, Morelli, Xavier, Collette, Yves
Publicado em 2007

HIV-1 Vif promotes the formation of high molecular mass APOBEC3G complexes

Por Goila-Gaur, Ritu, Khan, Mohammad A., Miyagi, Eri, Kao, Sandra, Opi, Sandrine, Takeuchi, Hiroaki, Strebel, Klaus
Publicado em 2007

Ca(2+)/calmodulin transfers the membrane-proximal lipid-binding domain of the v-SNARE synaptobrevin from cis to trans bilayers

Por de Haro, Luc, Ferracci, Géraldine, Opi, Sandrine, Iborra, Cécile, Quetglas, Stéphanie, Miquelis, Raymond, Lévêque, Christian, Seagar, Michael
Publicado em 2004

Alternative Splicing Modulates Autoinhibition and SH3 Accessibility in the Src Kinase Fyn

Por Brignatz, C., Paronetto, M. P., Opi, S., Cappellari, M., Audebert, S., Feuillet, V., Bismuth, G., Roche, S., Arold, S. T., Sette, C., Collette, Y.
Publicado em 2009

Monomeric APOBEC3G Is Catalytically Active and Has Antiviral Activity

Por Opi, Sandrine, Takeuchi, Hiroaki, Kao, Sandra, Khan, Mohammad A., Miyagi, Eri, Goila-Gaur, Ritu, Iwatani, Yasumasa, Levin, Judith G., Strebel, Klaus
Publicado em 2006

Stably Expressed APOBEC3F Has Negligible Antiviral Activity

Por Miyagi, Eri, Brown, Charles R., Opi, Sandrine, Khan, Mohammad, Goila-Gaur, Ritu, Kao, Sandra, Walker, Robert C., Hirsch, Vanessa, Strebel, Klaus
Publicado em 2010

Reservoir cells no longer detectable after a heterologous SHIV challenge with the synthetic HIV-1 Tat Oyi vaccine

Por Watkins, Jennifer D, Lancelot, Sophie, Campbell, Grant R, Esquieu, Didier, Mareuil, Jean de, Opi, Sandrine, Annappa, Sylvie, Salles, Jean-Pierre, Loret, Erwann P
Publicado em 2006

Viral RNA Is Required for the Association of APOBEC3G with Human Immunodeficiency Virus Type 1 Nucleoprotein Complexes

Por Khan, Mohammad A., Kao, Sandra, Miyagi, Eri, Takeuchi, Hiroaki, Goila-Gaur, Ritu, Opi, Sandrine, Gipson, Clay L., Parslow, Tristram G., Ly, Hinh, Strebel, Klaus
Publicado em 2005

Vif Counteracts a Cyclophilin A-Imposed Inhibition of Simian Immunodeficiency Viruses in Human Cells

Por Takeuchi, Hiroaki, Buckler-White, Alicia, Goila-Gaur, Ritu, Miyagi, Eri, Khan, Mohammad A., Opi, Sandrine, Kao, Sandra, Sokolskaja, Elena, Pertel, Thomas, Luban, Jeremy, Strebel, Klaus
Publicado em 2007

Structural recognition mechanisms between human Src Homology domain 3 (SH3) and ALG-2-Interacting protein X (Alix)

Por Shi, Xiaoli, Betzi, Stephane, Lugari, Adrien, Opi, Sandrine, Restouin, Audrey, Parrot, Isabelle, Martinez, Jean, Zimmermann, Pascale, Lecine, Patrick, Huang, Mingdong, Arold, Stefan T., Collette, Yves, Morelli, Xavier
Publicado em 2012

Mechanistic Studies of the Negative Epistatic Malaria-protective Interaction Between Sickle Cell Trait and α(+)thalassemia

Por Herbert Opi, D., Ochola, Lucy B., Tendwa, Metrine, Siddondo, Bethsheba R., Ocholla, Harold, Fanjo, Harry, Ghumra, Ashfaq, Ferguson, David J.P., Alexandra Rowe, J., Williams, Thomas N.
Publicado no EBioMedicine (2014)

Erratum to “Mechanistic Studies of the Negative Epistatic Malaria-protective Interaction Between Sickle Cell Trait and α(+)thalassemia” [EBioMedicine 1 (2014) 29–36]

Por Opi, D. Herbert, Ochola, Lucy B., Tendwa, Metrine, Siddondo, Bethsheba R., Ocholla, Harold, Fanjo, Harry, Ghumra, Ashfaq, Ferguson, David J.P., Rowe, J. Alexandra, Williams, Thomas N.
Publicado no EBioMedicine (2015)